Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,552.96
+774.94(+1.56%)

'We sold £1.5m of product sold in first week'

Lyma founder on rise of her wellness company

Antibe Therapeutics Inc. (ATBPF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.2156

0.0000

(0.00%)

At close: 03:46PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	2	1	4	3
Avg. Estimate	-0.11	-0.08	-0.33	-0.35
Low estimate	-0.14	-0.08	-0.42	-0.61
High estimate	-0.09	-0.08	-0.11	-0.14
Year ago EPS	-0.06	-0.08	-0.27	-0.33

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	2	1	4	3
Avg. Estimate	N/A	N/A	N/A	N/A
Low estimate	N/A	N/A	N/A	N/A
High estimate	N/A	N/A	N/A	N/A
Year ago sales	N/A	N/A	N/A	N/A
Sales growth (year/est)	N/A	N/A	N/A	N/A

Earnings history	30/12/2022	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.09	-0.07	-0.09	-0.11
Actual EPS	-0.06	-0.08	-0.07	-0.08
Difference	0.03	-0.01	0.02	0.03
Surprise %	33.30%	-14.30%	22.20%	27.30%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.11	-0.08	-0.33	-0.35
7 days ago	-0.11	-0.08	-0.33	-0.35
30 days ago	-0.08	-0.06	-0.24	-0.26
60 days ago	-0.09	-0.09	-0.3	-0.35
90 days ago	-0.08	-0.08	-0.32	-0.39

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	ATBPF	Industry	Sector(s)	S&P 500
Current qtr.	-83.30%	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	-22.20%	N/A	N/A	N/A
Next year	-6.10%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A